News Medical6h
ALPK2 identified as promising new therapeutic target for treatment of heart failure
Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...
Enzyme ALPK2: A therapeutic target for a lethal form of heart failure
Researchers from the Nagoya University Graduate School of Medicine identified an enzyme, alpha-kinase 2 (ALPK2) that is ...
Armed robbery in Revesby10h
ALPK2: New Target for Fatal Heart Failure Therapy
Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an ...